首页> 外文OA文献 >211: The significance of palifermin (Kepivance®) in reduction of oral mucositis (OM) incidence and acute graft versus host disease in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT)

【2h】

211: The significance of palifermin (Kepivance®) in reduction of oral mucositis (OM) incidence and acute graft versus host disease in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT)

机译：211：在进行了造血干细胞移植（HSCT）的血液系统恶性肿瘤患者中，palifermin（Kepivance®）在降低口腔粘膜炎（OM）发病率以及急性移植物抗宿主病方面的意义

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nasilowska-Adamska B.; Rzepecki P.; Manko J.; Czyz A.; Markiewicz M.; Fedorowicz I.; Tomaszewska A.; Piatkowska-Jakubas B.; Wrzesien-Kus A.; Bieniaszewska M.; Duda D.; Halaburda K.; Szczepinski A.; Lange A.; Hellman A.; Robak T.; Skotnicki A.; Jedrzejczak W.W.; Walewski J.; Holowiecki J.; Komarnicki M.; Dmoszynska A.; Warzocha K.; Marianska B.;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant. [J] . Nasilowska-Adamska B, Rzepecki P, Manko J, Bone marrow transplantation . 2007,第10期

机译：palifermin（Kepivance）对接受造血干细胞移植的血液病患者口腔黏膜炎和急性移植物抗宿主病的影响。
2. Elevated Pre-HSCT Ferritin is Not Associated with Increased Risk of Acute Graft Versus Host Disease in Patients with High Risk Sickle Cell Disease Undergoing Haploidentical T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) [J] . Yara Perez, Liana Klejmont, Harshini Mahanti, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：升高的预热素铁蛋白与高风险镰状细胞缺陷的同种异体造血干细胞移植（AllOhsct）的高风险镰状细胞病患者患者急性移植物与宿主病的风险增加无关
3. Elevated Pre-HSCT Ferritin is Not Associated with Increased Risk of Acute Graft Versus Host Disease in Patients with High Risk Sickle Cell Disease Undergoing Haploidentical T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) [J] . Yara Perez, Liana Klejmont, Harshini Mahanti, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：None
4. Extraorally delivered photobiomodulation therapy for prevention of oropharyngeal mucositis in pediatric patients undergoing hematopoietic cell transplantation [C] . Christine N. Duncan, Anna N. Yaroslavsky, Wendy B. London, Mechanisms of photobiomodulation therapy XII . 2017

机译：外用光生物调节疗法预防小儿造血细胞移植患者的口咽粘膜炎
5. The burden of parainfluenza virus infection in patients with hematological malignancy and hematopoietic stem cell transplant (HSCT) recipients in the absence of active immunization and approved therapy: The role of infection control. [D] . Hanmod, Santosh S. 2009

机译：在没有积极免疫和批准治疗的情况下，血液恶性肿瘤和造血干细胞移植（HSCT）患者的副流感病毒感染负担：感染控制的作用。
6. Efficacy of palifermin on oral mucositis and acute GVHD after hematopoietic stem cell transplantation (HSCT) in hematology malignancy patients: a meta-analysis of trials [O] . Hamid Reza Mozaffari, Mehrdad Payandeh, Mazaher Ramezani, 2017

机译：palifermin对血液系统恶性肿瘤患者造血干细胞移植（HSCT）后口腔黏膜炎和急性GVHD的疗效：一项试验的荟萃分析
7. Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis [O] . Stiff Patrick J., Leinonen Mika, Kullenberg Torbjörn, 2016

机译：帕利佛明预防自发性造血干细胞移植的血液系统恶性肿瘤患者的长期安全性结果可预防口腔粘膜炎

211: The significance of palifermin (Kepivance®) in reduction of oral mucositis (OM) incidence and acute graft versus host disease in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT)

著录项

引文网络

相似文献

相关主题

期刊订阅